Literature DB >> 3517865

Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5' exon (exon -1).

K Cichutek, P H Duesberg.   

Abstract

The hypothesis is tested that the ras gene of Harvey sarcoma virus (Ha-SV) and the proto-ras DNAs from certain tumor cells derive transforming function from specific codons in which they differ from normal proto-ras genes. Molecularly cloned Harvey proviral vectors carrying viral ras, normal rat proto-ras, and recombinant ras genes in which the virus-specific ras codons 12 and 59 were replaced by proto-ras equivalents each transformed aneuploid mouse 3T3 cells after latent periods that ranged from 4 to 10 days. Viruses with or without virus-specific ras codons all transformed diploid rat cells in 3-5 days equally well. However, in the absence of virus replication, mutant codons were beneficial for transforming function. Deletion of non-ras regions of Ha-SV did not affect transforming function. We conclude that specific ras codons are not necessary for transforming function. Comparisons of the ras sequences of Ha-SV, BALB SV, and Rasheed SV with sequences of proto-ras genes from rat and man revealed an upstream proto-ras exon, termed exon -1. The 3' end of this exon is present in all three viruses and in a ras pseudogene of the rat. Since ras genes transform without mutation and since exon -1 is truncated in viral ras genes and all transforming proto-ras DNAs of the Harvey and the Kirsten ras family, we propose that ras genes are activated by truncation of exon -1 either via viral transduction or artificially via cloning and transfection. The proposal implies that untruncated proto-ras genes with point mutations may not be cellular cancer genes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517865      PMCID: PMC323292          DOI: 10.1073/pnas.83.8.2340

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Host range of murine xenotropic virus: replication in avian cells.

Authors:  J A Levy
Journal:  Nature       Date:  1975-01-10       Impact factor: 49.962

2.  Transformation and virus growth by murine sarcoma viruses in human cells.

Authors:  S A Aaronson; G J Todaro
Journal:  Nature       Date:  1970-01-31       Impact factor: 49.962

3.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

4.  Variation in avian retrovirus genomes.

Authors:  J M Coffin; P N Tsichlis; C S Barker; S Voynow; H L Robinson
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences.

Authors:  M Lusky; M Botchan
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

6.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.

Authors:  S Sukumar; V Notario; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

7.  Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus.

Authors:  E M Scolnick; W C Vass; R S Howk; P H Duesberg
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

8.  Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus.

Authors:  R W Ellis; D DeFeo; J M Maryak; H A Young; T Y Shih; E H Chang; D R Lowy; E M Scolnick
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Ribonucleic acid components of murine sarcoma and leukemia viruses.

Authors:  J Maisel; V Klement; M M Lai; W Ostertag; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.

Authors:  D DeFeo; M A Gonda; H A Young; E H Chang; D R Lowy; E M Scolnick; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  28 in total

1.  Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.

Authors:  V Y Hua; W K Wang; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus.

Authors:  H Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  A splicing enhancer in the 3'-terminal c-H-ras exon influences mRNA abundance and transforming activity.

Authors:  D Y Hwang; J B Cohen
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Authors:  M Souyri; I Vigon; M Charon; P Tambourin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Activation of oncogenicity of the c-rel proto-oncogene.

Authors:  B S Sylla; H M Temin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Nucleotide sequence and characterization of the 5' flanking region of the rat Ha-ras protooncogene.

Authors:  G Damante; S Filetti; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Development of transforming function during transduction of proto-ras into Harvey sarcoma virus.

Authors:  M Lang; I Treinies; P H Duesberg; R Kurth; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  DNA recombination is sufficient for retroviral transduction.

Authors:  J R Schwartz; S Duesberg; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.

Authors:  J J O'Leary; R J Landers; I Silva; V Uhlmann; M Crowley; I Healy; K Luttich
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 10.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.